Cargando…

Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden

INTRODUCTION: Individuals with type 2 diabetes (T2D) are at high risk of experiencing atherosclerotic cardiovascular disease (ASCVD), which is associated with morbidity, mortality and healthcare resource utilisation. Clinical guidelines recommend the use of glucose-lowering medications with cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steen Carlsson, Katarina, Faurby, Mads, Nilsson, Kristoffer, Wolden, Michael Lyng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299967/ https://www.ncbi.nlm.nih.gov/pubmed/37326822 http://dx.doi.org/10.1007/s13300-023-01430-4

Ejemplares similares

Economic burden of atherosclerotic cardiovascular disease: a matched case–control study in more than 450,000 Swedish individuals
por: Steen Carlsson, Katarina, et al.
Publicado: (2023)

Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study
por: Aroda, Vanita R., et al.
Publicado: (2021)

Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital‐based care, days absent from work, costs and mortality
por: Persson, Sofie, et al.
Publicado: (2022)

Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
por: Nilsson, Kristoffer, et al.
Publicado: (2022)

Economic burden associated with chronic constipation in Sweden: a retrospective cohort study
por: Bruce Wirta, Sara, et al.
Publicado: (2014)

Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)
por: Evans, Marc, et al.
Publicado: (2022)

Economic burden of stroke in a large county in Sweden
por: Persson, Josefine, et al.
Publicado: (2012)

The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs
por: Kotsopoulos, Nikolaos, et al.
Publicado: (2022)

The burden of chickenpox disease in Sweden
por: Widgren, Katarina, et al.
Publicado: (2016)

Health Utilities of Type 2 Diabetes-Related Complications: A Cross-Sectional Study in Sweden
por: Kiadaliri, Aliasghar A., et al.
Publicado: (2014)

The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2017)

Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study
por: Melzer Cohen, Cheli, et al.
Publicado: (2017)

Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients
por: Calara, Paul S., et al.
Publicado: (2017)

Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States
por: Fonseca, Ana F, et al.
Publicado: (2023)

Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients
por: Yang, Junjie, et al.
Publicado: (2019)

Correction: The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2018)

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
por: Andersson, Emelie, et al.
Publicado: (2020)

Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
por: Evans, Marc, et al.
Publicado: (2021)

Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden
por: Kiadaliri, Aliasghar A., et al.
Publicado: (2014)

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes
por: Yeaw, Jason, et al.
Publicado: (2012)

Burden of herpes zoster and post-herpetic neuralgia in Sweden
por: Nilsson, Jonas, et al.
Publicado: (2015)

Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study
por: LÖFVENDAHL, Sofia, et al.
Publicado: (2023)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
por: Braae, Uffe Christian, et al.
Publicado: (2020)

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
por: Gonçalves, Isabel, et al.
Publicado: (2016)

Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study
por: Löfvendahl, Sofia, et al.
Publicado: (2022)

Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control
por: Tentolouris, Nikolaos, et al.
Publicado: (2019)

The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households
por: Finkelstein, Eric A., et al.
Publicado: (2014)

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
por: Journath, Gunilla, et al.
Publicado: (2017)

Diabetes Prevalence in Sweden at Present and Projections for Year 2050
por: Andersson, Tomas, et al.
Publicado: (2015)

Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden – A Population-Based Register Study
por: Löfvendahl, Sofia, et al.
Publicado: (2014)

A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in Canada
por: Qureshy, Kamran, et al.
Publicado: (2022)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium
por: Scheenstra, Bart, et al.
Publicado: (2022)

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
por: Mani, Venkatesh, et al.
Publicado: (2009)

Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study
por: Bernfort, Lars, et al.
Publicado: (2020)

Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data
por: Kaku, Kohei, et al.
Publicado: (2017)

A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function
por: Brod, M, et al.
Publicado: (2013)

Primary Sjögren’s Syndrome: A Retrospective Cohort Study of Burden of Illness in Sweden
por: Westerlund, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19g4dl4vh7tt6qjubhi6o5i1tv